المؤلفون: Arvinder Sran, Kunbin Qu, Sambaiah Thota, David L. Carroll, Sacha Holland, Tarikere Gururaja, Christian Franci, Vanessa Taylor, D. Wayne Lang, Yonchu Jenkins, Rajinder Singh, George Clemens, Muhammad Baluom, Caroline M. R. Low, Elliott B. Grossbard, Steve Wong, Taisei Kinoshita, Donald G. Payan, Joe Lasaga, John R. McLaughlin, Ankush Argade, Angela Romane, Yanhong Zhu, Betty Chang, David J. Sweeny, Hui Li, Weiduan Xu, Yasumichi Hitoshi, Manjeet Parmer, Polly Pine, Vadim Markovtsov, Feifei Zhao, Erlina Pali, Marina Gelman

المصدر: Journal of Cancer Research and Clinical Oncology. 136:99-113

مصطلحات موضوعية: Cancer Research, Pathology, medicine.medical_specialty, Phenotypic screening, Drug Evaluation, Preclinical, Aurora inhibitor, Mice, Nude, Apoptosis, HL-60 Cells, Mice, Inbred Strains, Mice, SCID, Protein Serine-Threonine Kinases, Mice, Aurora kinase, Aurora Kinases, Mice, Inbred NOD, Cell Line, Tumor, Animals, Humans, Medicine, Endoreduplication, Protein Kinase Inhibitors, Cells, Cultured, Cell Proliferation, Protein-Serine-Threonine Kinases, Dose-Response Relationship, Drug, business.industry, Kinase, Cell growth, Cell Cycle, General Medicine, Cell cycle, Flow Cytometry, Norbornanes, Survival Analysis, Xenograft Model Antitumor Assays, Pyrimidines, Microscopy, Fluorescence, Oncology, Cancer research, Female, business, HeLa Cells

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab479d6b26786855ba421ed04ab73684
https://doi.org/10.1007/s00432-009-0641-1